Fidelis Capital Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
27,283
+11,533
| +73% | +$276K | 0.06% | 231 |
|
|
2025
Q1 | $361K | Sell |
15,750
-8,768
| -36% | -$201K | 0.04% | 292 |
|
|
2024
Q4 | $642K | Sell |
24,518
-1,317
| -5% | -$34.5K | 0.06% | 220 |
|
|
2024
Q3 | $746K | Buy |
25,835
+1,267
| +5% | +$36.6K | 0.09% | 190 |
|
|
2024
Q2 | $709K | Buy |
24,568
+412
| +2% | +$11.9K | 0.1% | 169 |
|
|
2024
Q1 | $670K | Buy |
24,156
+4,676
| +24% | +$130K | 0.1% | 179 |
|
|
2023
Q4 | $561K | Sell |
19,480
-404
| -2% | -$11.6K | 0.12% | 157 |
|
|
2023
Q3 | $653K | Sell |
19,884
-2,607
| -12% | -$85.6K | 0.22% | 107 |
|
|
2023
Q2 | $825K | Buy |
22,491
+1,182
| +6% | +$43.4K | 0.3% | 78 |
|
|
2023
Q1 | $820K | Buy |
21,309
+9,356
| +78% | +$360K | 0.35% | 71 |
|
|
2022
Q4 | $578K | Buy |
+11,953
| New | +$578K | 0.68% | 48 |
|